1. Home
  2. NXPL vs GDTC Comparison

NXPL vs GDTC Comparison

Compare NXPL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • GDTC
  • Stock Information
  • Founded
  • NXPL 1997
  • GDTC 2018
  • Country
  • NXPL United States
  • GDTC Singapore
  • Employees
  • NXPL N/A
  • GDTC N/A
  • Industry
  • NXPL Telecommunications Equipment
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • GDTC Health Care
  • Exchange
  • NXPL Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • NXPL 17.9M
  • GDTC 21.5M
  • IPO Year
  • NXPL N/A
  • GDTC 2023
  • Fundamental
  • Price
  • NXPL $0.86
  • GDTC $1.88
  • Analyst Decision
  • NXPL
  • GDTC Buy
  • Analyst Count
  • NXPL 0
  • GDTC 1
  • Target Price
  • NXPL N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • NXPL 129.9K
  • GDTC 14.8K
  • Earning Date
  • NXPL 11-13-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • NXPL N/A
  • GDTC N/A
  • EPS Growth
  • NXPL N/A
  • GDTC N/A
  • EPS
  • NXPL N/A
  • GDTC N/A
  • Revenue
  • NXPL $58,766,000.00
  • GDTC $368,838.00
  • Revenue This Year
  • NXPL N/A
  • GDTC $5.37
  • Revenue Next Year
  • NXPL N/A
  • GDTC N/A
  • P/E Ratio
  • NXPL N/A
  • GDTC N/A
  • Revenue Growth
  • NXPL N/A
  • GDTC N/A
  • 52 Week Low
  • NXPL $0.43
  • GDTC $1.20
  • 52 Week High
  • NXPL $2.30
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 66.23
  • GDTC 46.04
  • Support Level
  • NXPL $0.69
  • GDTC $1.82
  • Resistance Level
  • NXPL $0.74
  • GDTC $2.28
  • Average True Range (ATR)
  • NXPL 0.05
  • GDTC 0.12
  • MACD
  • NXPL 0.01
  • GDTC 0.00
  • Stochastic Oscillator
  • NXPL 90.91
  • GDTC 13.04

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: